Stem Cell Resources
Human Pluripotent Stem Cell Banks
These academic and private stem cell derivation and banking facilities provide a variety of serivces and pluripotent stem cell lines for researchers around the world.
ATCC Stem Cell Center
ATCC has provided stem cell resources to the research community for more than a decade, with a growing portfolio of cultures to choose from, including mouse embryonic stem cells, human embryonic stem cells, human mesenchymal stem cells (MSC), and human iPS cells.
Coriell Institute Stem Cell Biobank
The mission of the Stem Cell Biobank (SCB) at the Coriell Institute for Medical Research is to provide scientists with the opportunity to bank their pluripotent stem cell lines at the SCB, and to develop in-house induced pluripotent stem cell (iPSC) lines for distribution to researchers. Established in 2008, the SCB has developed core capabilities to maintain, characterize, bank, and distribute important stem cell resources.
The WISC Bank at WiCell Research Institute provides human embryonic stem cell lines previously distributed by the National Stem Cell Bank. WISC bank distributes research grade and clinical grade hESC lines as well as iPS cell lines.
Genea Stem Cells
This Australian company is currently the world’s largest private bank of human ES cells. It distributes more than 100 cell lines representing almost 30 genetic diseases and a variety of genetic backgrounds, all derived in full compliance with international ethical and regulatory guidelines.
UK Stem Cell Bank
The UK bank was created to provide quality controlled stocks of stem cells that researchers worldwide can rely on to facilitate high quality and standardized research. It currently provides 22 hES cell lines.
Spanish National Stem Cell Bank
The Banco Nacional de Líneas Celulares (National Stem Cell Bank) is set up as a network structure with several nodes coordinated by one central node. The aim of this structure is to ensure that throughout the country there are human embryonic stem cells and adult stem cells available for biomedical research. This Bank currently has abour 36 hES and 35 iPS cell lines available. Nodes of this national bank are the Stem Cell Bank of Barcelona and the Andalusian Stem Cell Bank.
Academic Stem Cell Core Facilities
Boston University Center for Regenerative Medicine (CReM) iPS Cell Bank
This bank provides a number of disease-specific iPScell lines derived using the STEMCCA lentivirus vector developed at BU.
Children's Hospital, Boston hESC Core
This hESC Core Facility functions as a centralized source for the collection, expansion, analysis and banking of human ES cell lines.
Harvard Stem Cell Institute iPS Core Facility
This core facility is dedicated to the derivation and distribution of disease-specific iPS cell lines.
UCSD Stem Cell Facility
The UCSD Human Stem Cell Core Facility banks 8 hESC lines.
UConn Stem Cell Core
The University of Connecticut Health Center Stem Cell Core facility banks 12 hESC lines and 6 iPS cell lines.
Stem Cell Institutes and Centers
California Institute for Regenerative Medicine
California’s stem cell agency was created by the voters of California in 2004 when they passed Proposition 71, which authorized $3 billion in funding for stem cell research in California. The agency funds stem cell research at institutions throughout California with the goal of developing new therapies for deadly diseases and disorders.
Harvard Stem Cell Institute
HSCI was founded in 2004 to draw Harvard's resources (consisting of the university, medical school and 11 teaching hospitals and research institutions) together by establishing a cooperative community of scientists and practitioners, developing new ways to fund and support research, and promoting opportunities for open communication and education. The Harvard Stem Cell Institute is a gathering place for a whole community of scientists and clinical experts in stem cell science seeking to bring new treatments to the clinic, and new life to patients with a wide range of chronic illnesses.
NIH Center for Regenerative Medicine
The NIH Center for Regenerative Medicine (NIH CRM) is a community resource that works to provide the infrastructure to support and accelerate the clinical translation of stem cell-based technologies, and to develop widely available resources to be used as standards in stem cell research. The Center collaborates in the U.S. and internationally — including governments, research institutions and commercial entities — to ensure that efforts are coordinated and standard policies are in place to minimize roadblocks to advancing stem cell technologies. The Center for Regenerative Medicine is funded by the NIH Common Fund.
Stem Cell Networks and Societies
International Society for Stem Cell Research
ISSCR is an independent, nonprofit organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research.
Interstate Alliance for Stem Cell Research
IASCR is a voluntary body whose mission is to advance stem cell research (human embryonic, adult, and other) by fostering effective interstate collaboration, by assisting states in developing research programs, and by promoting efficient and responsible use of public funds.
International Consortium of Stem Cell Networks
A network of national stem cell research organizations funded by government with mandates to promote collaboration and training, conduct outreach, and facilitate economic development in the stem cell space.
Human Stem Cell Registries
National Institutes of Health
The NIH Human Embryonic Stem Cell Registry lists human embryonic stem cell lines that are approved for federal funding.
European human ES Cell Registry
The European Human Embryonic Stem Cell Registry (hESCreg) launched in January, 2008. This continually expanding registry collects data from project teams and hESC line providers and currently lists over 600 cell lines.
International Stem Cell Characterization Initiative
Worldwide effort to characterize 58 human ES cell lines in 18 laboratories from 10 countries. Each cell line in the registry is searchable by name and laboratory that analyzed it.